In contrast, it was reported that pharmacological inhibition of HO-1 (Costa et al., 2016, Scharn et al., 2016) results in reduced Mtb burden, suggesting that HO-1 promotes TB. This evidence concerns the gene HMOX1 and tuberculosis.